Reason for request
Reassessment of the IAB.
Clinical Benefit
| Substantial |
Le service médical rendu par ces spécialités reste important.
|
Clinical Added Value
| minor |
la Commission maintient l'ASMR IV attribuée le 2 juin 2004 à RISPERDALCONSTA en tant que modalité d'administration susceptible d'améliorer la prise en charge de ces patients.
|
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
mZhyz5m2qHMkLeT9
